首页|共面与非共面模板在肺癌125I粒子植入治疗中的应用

共面与非共面模板在肺癌125I粒子植入治疗中的应用

扫码查看
目的 基于 3D打印共面与非共面模板分别设计肺癌患者的 125I粒子植入治疗计划,比较两种计划的剂量学差异,为临床使用提供依据.方法 选取2018年1月至2023年5 月于福建省肿瘤医院进行 125I粒子植入治疗的 25 例肺癌患者,均采用近距离放射治疗计划系统设计共面与非共面模板辅助的 125I粒子植入治疗计划,要求共面与非共面计划的肿瘤靶区(GTV)处方剂量覆盖 90%以上的GTV.比较两种计划的插值针数、粒子数及GTV剂量学参数[包括 90%和 100%GTV体积受照射剂量D90%和D100%,100%、150%和 200%处方剂量的体积百分比V100、V150 和V200,适形性指数(CI)、GTV外体积指数(EI)和均匀性指数(HI)]与危及器官(OAR)剂量学参数(患侧肺接受 20 Gy的体积百分比V20 和平均剂量Dmean、脊髓最大受照射剂量Dmax).结果 共面计划的插值针数、粒子数均多于非共面计划,差异均有统计学意义(P<0.05).两种计划的D90%、D100%、V100、V200、EI和HI比较,差异均无统计学意义(P>0.05);共面计划的V150 高于非共面计划,CI低于非共面计划,差异均有统计学意义(P<0.05).共面计划的患侧肺V20、Dmean和脊髓Dmax均高于非共面计划,但差异均无统计学意义(P>0.05).结论 肺癌患者采用共面与非共面模板辅助 125I粒子植入治疗均可达到靶区剂量覆盖要求,非共面计划的插值针数、粒子数和剂量适形性等计划参数优于共面计划,重要危及器官的吸收剂量也低于共面计划,但价格较昂贵,故临床需要根据具体情况进行选择.
The Comparison of Treatment Plans Between Coplanar Versus Non-Coplanar Template-Assisted 125I Particle Implantation for Lung Cancer
Objective To design 125I particle implantation treatment plans for lung cancer patients based on 3D printed coplanar and non-coplanar templates,compare the dosimetric differences between the two plans,and provide a basis for clinical use.Methods With the seletion of 25 lung cancer patients who underwent 125I particle implantation treatment at Fujian Cancer Hospital from January 2018 to May 2023,the design of a close range radiation therapy planning system with 125I particle implantation assisted by coplanar and non-coplanar templates was adopted,requiring that the prescription dose of gross target volume(GTV)in both coplanar and non-coplanar plans cover more than 90%of GTV.Interpolating needle counts,particle counts,and GTV dosimetry parameters for both plans[including D90%and D100%with 90%and 100%GTV volume exposure doses,and V100,V150 and V200 with volume percentage of 100%,150%and 200%prescribed dose,the conformance index(CI),GTV external index(EI),and homogeneity index(HI)],the organ at risk(OAR)dosimetry parameters(V20 with percentage of volume receiving 20 Gy and mean dose Dmean,maximum spinal cord exposure dose Dmax)were compared.Results The interpolation needle number and particle number of coplanar plan were higher than those of non-coplanar plan,and the differences were statistically significant(P<0.05).There were no significant differences in D90%,D100%,V100,V200,EI and HI between the two plans(P>0.05);The V150 of coplanar plans was higher than that of non-coplanar plans,and the CI was lower than that of non-coplanar plans,with statistical significance(P<0.05).The V20 and Dmean of the affected lung and Dmax of the spinal cord in the coplanar plans were higher than those in the non-coplanar plans,but the differences were not statistically significant(P>0.05).Conclusion For lung cancer patients,both coplanar and non-coplanar template-assisted 125I particles implantation can meet the clinical target dose coverage requirements.The plan parameters such as the number of needles,the number of seeds and dose conformity of the non-coplanar plan are better than those of the coplanar plan,and the absorbed dose of important organs at risk is lower than that of the coplanar plan,but the price is more expensive,so the clinical selection needs to be made according to the specific situation.

125I particlesCoplanar templateNon-coplanar templateLung cancerTreatment plan

陈济鸿

展开 >

福建医科大学肿瘤临床医学院·福建省肿瘤医院 (福建福州 350014)

125I粒子 共面模板 非共面模板 肺癌 治疗计划

福建省肿瘤放射与免疫治疗临床医学研究中心项目福建省卫生健康科技项目福建省科技计划福建省科技联合创新项目

2020Y20122021CXB0132021Y00522021Y9190

2024

医疗装备
国家食品药品监督管理局北京医疗器械质量监督检验中心 北京市医疗器械检验所

医疗装备

影响因子:0.339
ISSN:1002-2376
年,卷(期):2024.37(9)
  • 16